1
|
Shaw AR, Perales-Puchalt J, Johnson E, Espinoza-Kissell P, Acosta-Rullan M, Frederick S, Lewis A, Chang H, Mahnken J, Vidoni ED. Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review. J Prev Alzheimers Dis 2022; 9:113-118. [PMID: 35098981 DOI: 10.14283/jpad.2021.49] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Despite older racial and ethnic minorities (REMs) being more likely to develop dementia they are underrepresented in clinical trials focused on neurological disorders. Inclusion of REMs in dementia prevention studies is vital to reducing the impact of disparities in dementia risk. We conducted a systematic review to characterize the number of REM enrolled in brain health and prevention randomized controlled trials (RCTs). RTCs published from January 1, 2004 to April 21, 2020 were included. Participants were normal cognitive adults aged 45 years and older who participated in a Phase II or Phase III U.S. based preventative trial. Analyses were performed to examine differences in trial characteristics between RCTs that did and those that did not report race/ethnicity and to calculate the pooled proportion of each racial/ethnic group in randomized brain healthy prevention trials. A total of 42 studies consisting of 100,748 participants were included in the final analyses. A total of 26 (62%) reported some racial/ethnic identity data. The pooled proportion of REM participants was 0.256 (95% CI, 0.191, 0.326). There is a lack of racial/ethnic reporting of participants and REMs remain underrepresented in brain health prevention RCTs.
Collapse
Affiliation(s)
- A R Shaw
- Eric Vidoni, 4350 Shawnee Mission Parkway, Fairway, KS, 66205, USA, ; Phone: 913-588-5312; Fax: 913-945-5035
| | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Shaw AR, Perales-Puchalt J, Moore T, Weatherspoon P, Robinson M, Hill CV, Vidoni ED. Recruitment of Older African Americans in Alzheimer's Disease Clinical Trials Using a Community Education Approach. J Prev Alzheimers Dis 2022; 9:672-678. [PMID: 36281671 PMCID: PMC9514712 DOI: 10.14283/jpad.2022.82] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 08/31/2022] [Indexed: 11/11/2022]
Abstract
Alzheimer's disease and related dementias (ADRD) is two times more prevalent among compared to non-Hispanic Whites. Despite the higher prevalence of ADRD among older African Americans, recent estimates suggest research enrollment by those who identify as African American remains limited. The purpose of the study is to 1) explore how a culturally tailored community education program impacts clinical trial interest and enrollment in ADRD research studies and to 2) identify how applicable the African American community perceived the culturally tailored curriculum. Using a community-engaged research approach, we collaborated with predominately African American serving community-based organizations to support content development and delivery of Aging with Grace (AWG), a culturally tailored ADRD educational curriculum. A total of five AWG presentations were given to 66 attendees. Most attendees (67%) expressed interest in participating in clinical trials after attending AWG. Enrollment increased within an observational study (84%) and lifestyle prevention clinical trials (52%) from 2018 to 2019. Attendees (32%) also perceived an increase in ADRD knowledge from attending AWG and 89.1% believed more African Americans should participate in research. Our work demonstrates the effectiveness of a culturally tailored community education program to enhance knowledge, clinical trial interest, and recruitment into observational studies and lifestyle ADRD clinical trials among older African Americans. Education programs developed in partnership with the community can serve as bridge to research participation for underrepresented minorities in clinical research. Future studies should assess long-term retention of knowledge and research readiness.
Collapse
Affiliation(s)
- A R Shaw
- Eric Vidoni, PhD, 4350 Shawnee Mission Parkway, Fairway, KS, 66205, USA, Phone: 913-588-5312; Fax: 913-945-5035,
| | | | | | | | | | | | | |
Collapse
|
3
|
Fabian CJ, Klemp JR, Burns JM, Vidoni ED, Nydegger JL, Kreutzjans AL, Phillips TL, Baker HA, Hendry B, John C, Amin AL, Khan QJ, Mitchell MP, O'Dea AP, Sharma P, Wagner JL, Hursting SD, Kimler BF. Abstract P6-12-11: Feasibility and biomarker modulation due to high levels of moderate to vigorous physical activity as part of a weight loss intervention in older, sedentary, obese breast cancer survivors. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-12-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
We sought to demonstrate that older, sedentary, obese breast cancer survivors could achieve > 200 minutes per week of moderate to vigorous physical activity (MVI PA) as part of a weight loss intervention; and to assess modulation of risk biomarkers. This level of PA in combination with moderate calorie restriction is associated with weight losses of >10% in women without cancer, which in turn is associated with significant modulation of cancer risk biomarkers.
Eleven participants with BMI > 30 kg/m2 enrolled in a 12-week program that consisted of moderate caloric restriction, weekly phone group behavioral sessions, and individualized exercise plans based on measured heart rate reserve. Women were provided an accelerometer with heart rate monitor linked to GarminConnect, membership to a YMCA, twice weekly supervised exercise sessions with a personal trainer, and weekly feedback regarding weight and physical activity progress. The goal was to increase MVI PA (≥45% heart rate reserve) gradually from <60 to >200 minutes per week.
The median age was 61, 5/11 women had received prior chemotherapy, and 7/11 were currently taking aromatase inhibitors. Median values of baseline anthropomorphic measures acquired by dual energy x-ray absorptiometry (GE Lunar iDXA) included BMI, 37.3 kg/m2; total mass, 97.5 kg; fat mass, 47.6 kg; visceral fat, 1.7 kg (range 1.4-3.0); and fat mass index, 17.6 kg/m2. The majority had a baseline VO2 peak in the poor range for their age. All 11 participants completed the intervention, with no reported serious adverse events. Median MVI PA achieved over weeks 5-12 was 161 minutes/week (range 48-320). VO2 peak was increased in 10/11 with a median relative change of 12% from baseline. All but one lost weight with an overall median of 8% total mass loss, which was associated with 13% total fat mass loss and 21% visceral fat mass loss. For those with MVI PA above the median, values were 11%, 17%, and 40%, respectively. Visceral fat mass loss was linearly correlated with minutes per week of MVI PA (p=0.032); these parameters in turn were associated with changes in a number of serum biomarkers, including adiponectin-leptin ratio, TNF-alpha, as well as circulating adipose stromal cells, a potential marker for metastasis. Insulin and hs-CRP were favorably modulated in almost all participants but change was not linearly correlated with activity or mass loss parameters; thus these may not be ideal biomarkers to document a dose response to level of MVI PA.
Conclusion: These results demonstrate that older, sedentary, obese breast cancer survivors can safely achieve a high level of MVI PA when provided a structured program that includes an exercise trainer. It is feasible to design a clinical trial for such breast cancer survivors to examine biomarker modulation as a function of level of physical activity.
Citation Format: Fabian CJ, Klemp JR, Burns JM, Vidoni ED, Nydegger JL, Kreutzjans AL, Phillips TL, Baker HA, Hendry B, John C, Amin AL, Khan QJ, Mitchell MP, O'Dea AP, Sharma P, Wagner JL, Hursting SD, Kimler BF. Feasibility and biomarker modulation due to high levels of moderate to vigorous physical activity as part of a weight loss intervention in older, sedentary, obese breast cancer survivors [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-12-11.
Collapse
Affiliation(s)
- CJ Fabian
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - JR Klemp
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - JM Burns
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - ED Vidoni
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - JL Nydegger
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - AL Kreutzjans
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - TL Phillips
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - HA Baker
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - B Hendry
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - C John
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - AL Amin
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - QJ Khan
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - MP Mitchell
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - AP O'Dea
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - P Sharma
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - JL Wagner
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - SD Hursting
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| | - BF Kimler
- University of Kansas Medical Center, Kansas City, KS; University of North Carolina, Chapel Hill, NC
| |
Collapse
|
4
|
Laffer A, Sandoval R, Blocker E, Vidoni E, Watts A, Burns J, Sullivan D. ASSESSMENT OF HEALTH-PROMOTING BEHAVIORS BEFORE AND AFTER AN ALZHEIMER’S PREVENTION PROGRAM. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A. Laffer
- University of Kansas, Lawrence, Kansas,
| | - R. Sandoval
- University of Kansas Medical Center, Fairway, Kansas
| | - E. Blocker
- University of Kansas Medical Center, Fairway, Kansas
| | - E. Vidoni
- University of Kansas Medical Center, Fairway, Kansas
| | - A. Watts
- University of Kansas, Lawrence, Kansas,
| | - J. Burns
- University of Kansas Medical Center, Fairway, Kansas
| | - D.K. Sullivan
- University of Kansas Medical Center, Fairway, Kansas
| |
Collapse
|
5
|
Loskutova N, Bullard E, Venable W, Smail C, Vidoni E. E-INTERACTION WITH CONSENSUS-BASED RESOURCES FOR DETECTION AND MANAGEMENT OF DEMENTIA IN PRIMARY CARE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N. Loskutova
- National Research Network, American Academy of Family Physicians, Leawood, Kansas,
| | - E.M. Bullard
- National Research Network, American Academy of Family Physicians, Leawood, Kansas,
| | - W.R. Venable
- National Research Network, American Academy of Family Physicians, Leawood, Kansas,
| | - C. Smail
- National Research Network, American Academy of Family Physicians, Leawood, Kansas,
| | - E. Vidoni
- University of Kansas Medical Center, Kansas City, Kansas
| |
Collapse
|
6
|
Morris JK, Vidoni ED, Perea RD, Rada R, Johnson DK, Lyons K, Pahwa R, Burns JM, Honea RA. Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience 2014; 270:139-47. [PMID: 24735819 DOI: 10.1016/j.neuroscience.2014.04.006] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Revised: 04/01/2014] [Accepted: 04/02/2014] [Indexed: 02/08/2023]
Abstract
The goal of this study was to compare insulin resistance in aging and aging-related neurodegenerative diseases, and to determine the relationship between insulin resistance and gray matter volume (GMV) in each cohort using an unbiased, voxel-based approach. Insulin resistance was estimated in apparently healthy elderly control (HC, n=21) and neurodegenerative disease (Alzheimer's disease (AD), n=20; Parkinson's disease (PD), n=22) groups using Homeostasis Model Assessment of Insulin Resistance 2 (HOMA2) and intravenous glucose tolerance test (IVGTT). HOMA2 and GMV were assessed within groups through General Linear Model multiple regression. We found that HOMA2 was increased in both AD and PD compared to the HC group (HC vs. AD, p=0.002, HC vs. PD, p=0.003), although only AD subjects exhibited increased fasting glucose (p=0.005). Furthermore, our voxel-based morphometry analysis revealed that HOMA2 was related to GMV in all cohorts in a region-specific manner (p<0.001, uncorrected). Significant relationships were observed in the medial prefrontal cortex (HC), medial temporal regions (AD), and parietal regions (PD). Finally, the directionality of the relationship between HOMA2 and GMV was disease-specific. Both HC and AD subjects exhibited negative relationships between HOMA2 and brain volume (increased HOMA2 associated with decreased brain volume), while a positive relationship was observed in PD. This cross-sectional study suggests that insulin resistance is increased in neurodegenerative disease, and that individuals with AD appear to have more severe metabolic dysfunction than individuals with PD or PD dementia.
Collapse
Affiliation(s)
- J K Morris
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States; Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| | - E D Vidoni
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States; Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| | - R D Perea
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States; Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| | - R Rada
- Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| | - D K Johnson
- Department of Psychology, University of Kansas, Lawrence, KS, United States.
| | - K Lyons
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
| | - R Pahwa
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
| | - J M Burns
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States; Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| | - R A Honea
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States; Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS, United States.
| |
Collapse
|
7
|
Abstract
OBJECTIVE Both low and high body mass index (BMI) has been associated with cognitive impairment and dementia risk, including Alzheimer disease (AD). We examined the relationship of BMI with potential underlying biological substrates for cognitive impairment. METHODS We analyzed cross-sectional data from participants enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI) with PET imaging using Pittsburgh Compound B (PiB, n = 101) or CSF analyses (n = 405) for β-amyloid peptide (Aβ) and total tau. We assessed the relationship of CSF biomarkers and global PiB uptake with BMI using linear regression controlling for age and sex. We also assessed BMI differences between those who were and were not considered biomarker positive. Finally, we assessed BMI change over 2 years in relationship to AD biomarkers. RESULTS No dementia, mild cognitive impairment (MCI), and AD groups were not different in age, education, or BMI. In the overall sample, CSF Aβ (β = 0.181, p < 0.001), tau (β = -0.179, p < 0.001), tau/Aβ ratio (β = -0.180, p < 0.001), and global PiB uptake (β = -0.272, p = 0.005) were associated with BMI, with markers of increased AD burden associated with lower BMI. Fewer overweight individuals had biomarker levels indicative of pathophysiology (p < 0.01). These relationships were strongest in the MCI and no dementia groups. CONCLUSIONS The presence and burden of in vivo biomarkers of cerebral amyloid and tau are associated with lower BMI in cognitively normal and MCI individuals. This supports previous findings of systemic change in the earliest phases of the disease. Further, MCI in those who are overweight may be more likely to result from heterogeneous pathophysiology.
Collapse
Affiliation(s)
- E D Vidoni
- Department of Neurology, University of Kansas School of Medicine, Kansas City, KS 66160, USA
| | | | | | | | | |
Collapse
|
8
|
Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 2010; 74:113-20. [PMID: 20065246 DOI: 10.1212/wnl.0b013e3181c918cb] [Citation(s) in RCA: 83] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
OBJECTIVE A consistently identified risk factor for Alzheimer disease (AD) is family history of dementia, with maternal transmission significantly more frequent than paternal transmission. A history of maternal AD may be related to AD-like glucose consumption in cognitively healthy subjects. In this cross-sectional study, we tested whether cognitively healthy people with a family history of AD have less gray matter volume (GMV), an endophenotype for late-onset AD, than individuals with no family history, and whether decreases in GMV are different in subjects with a maternal family history. METHODS As part of the Kansas University Brain Aging Project, 67 cognitively intact individuals with a maternal history of late-onset AD (FHm, n = 16), a paternal history of AD (FHp, n = 8), or no parental history of AD (FH-, n = 43), similar in age, gender, education, and Mini-Mental State Examination score, were scanned at 3 T. We used voxel-based morphometry to examine GMV differences between groups, controlling for age, gender, and apoE4. RESULTS Cognitively healthy individuals with a family history of late-onset AD had significantly decreased GMV in the precuneus, middle frontal, inferior frontal, and superior frontal gyri compared with FH- individuals. FHm subjects had significantly smaller inferior frontal, middle frontal, precuneus, and lingual gyri compared with FH- and FHp subjects. CONCLUSIONS Overall, maternal family history of Alzheimer disease (AD) in cognitively normal individuals is associated with lower gray matter volume in AD-vulnerable brain regions. These data complement and extend reports of cerebral metabolic differences in subjects with a maternal family history.
Collapse
Affiliation(s)
- R A Honea
- University of Kansas School of Medicine, Department of Neurology, 2100 West 36th Ave., Suite 110, Kansas City, KS 66160, USA.
| | | | | | | | | |
Collapse
|
9
|
Boyd LA, Vidoni ED, Siengsukon CF, Wessel BD. Manipulating time-to-plan alters patterns of brain activation during the Fitts' task. Exp Brain Res 2009; 194:527-39. [PMID: 19214489 DOI: 10.1007/s00221-009-1726-4] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2008] [Accepted: 01/23/2009] [Indexed: 11/29/2022]
Abstract
Fitts' law predicts that there is an essential trade-off between speed and accuracy during movement. Past investigations of Fitts' law have not characterized whether advance planning of upcoming fast and accurate movements impacts either behavior or patterns of brain activation. With an event-related functional magnetic resonance imaging (fMRI) paradigm, we investigated the neural correlates of advance planning and movement difficulty of rapid, goal-directed aimed movements using a discrete version of the classic Fitts' task. Our behavioral data revealed strong differences in response time, initial movement velocity, and end-point accuracy based on manipulation of both time to plan movements and response difficulty. We discovered a modulation of the neural network associated with executing the Fitts' task that was dependent on the availability of time to plan the upcoming movement and motor difficulty. Specifically, when time to plan for the upcoming movement was available, medial frontal gyrus (BA 10), pre-SMA (BA 6), putamen and cerebellar lobule VI were uniquely active to plan movements. Further, their activation correlated with behavioral measures of movement. In contrast, manipulating movement difficulty invoked a different pattern of brain activations in regions that are known to participate in motor control, including supplementary motor area (BA 6), sensory motor cortex (BA 4, 3, 2) and putamen. Our finding that medial frontal gyrus (BA 10) was important for discrete, fast and accurate movements expands the known role of this brain region, which in the past has been identified as a cognitive processing system supporting stimulus-oriented attending. We now extend this conceptualization to include motor functions such as those employed for processing for rapid, goal-directed aimed movements.
Collapse
Affiliation(s)
- Lara A Boyd
- Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada.
| | | | | | | |
Collapse
|
10
|
Smirnova IV, Kibiryeva N, Vidoni E, Bunag R, Stehno-Bittel L. Abnormal EKG stress test in rats with type 1 diabetes is deterred with low-intensity exercise programme. Acta Diabetol 2006; 43:66-74. [PMID: 17143783 DOI: 10.1007/s00592-006-0215-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2005] [Accepted: 06/27/2006] [Indexed: 11/29/2022]
Abstract
The focus of this study was to determine whether minimal levels of exercise could halt the formation of diabetes-induced heart pathology. Seven-week-old male rats were divided into four groups: sedentary nondiabetic, exercise-trained non-diabetic, sedentary diabetic and exercise-trained diabetic. Individualised exercise programmes were based on the animal's tolerance, and continued for 7 weeks after the induction of diabetes. At the completion of the study, no differences were found in skeletal muscle citrate synthase activity between diabetic sedentary and exercise-trained rats, indicating that the exercise was low intensity. Diabetes-induced heart hypertrophy was not reversed with exercise as measured by heart-to-body weight ratios and EKG (R wave height). There was no statistical difference between groups in the response to an exercise stress test prior to the induction of diabetes. However, 4 weeks of diabetes resulted in a significant decrease in resting and post-stress test heart rates (9% and 20%, respectively), which remained depressed at week 7. The sedentary diabetic animals demonstrated an abnormal response during the recovery period of the EKG exercise test, which was not present in non-diabetic or exercise-trained diabetic animals. In conclusion, lowintensity exercise training improved the cardiac response to an exercise stress test in diabetic animals.
Collapse
Affiliation(s)
- I V Smirnova
- Department of Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS, USA
| | | | | | | | | |
Collapse
|